Jiaxinhai RBY-4B Drug Disintegration Tester

Overview

The Jiaxinhai RBY-4B Drug Disintegration Tester is a precision-engineered laboratory instrument designed to evaluate the disintegration behavior of solid oral dosage forms—including tablets, capsules, and suppositories—under standardized pharmacopeial conditions. It operates in accordance with the fundamental principles of mechanical agitation and controlled thermal immersion, simulating physiological dissolution environments as defined by major pharmacopeias (e.g., USP <701>, ChP 2020 Edition Section II, and EP 2.9.1). The device employs a vertically oscillating basket assembly immersed in a thermostatically regulated water bath (typically maintained at 37.0 ± 0.5 °C), where sample units are subjected to repetitive up-and-down motion at a fixed frequency (typically 29–32 cycles per minute) for predetermined time intervals. This methodology provides objective, reproducible assessment of tablet matrix breakdown and active ingredient release readiness—serving as a critical quality control checkpoint prior to dissolution or bioavailability studies.

Key Features

• Compliant dual-basket configuration with stainless-steel mesh (mesh size per USP specifications) and rigid vertical guidance rods ensuring consistent stroke amplitude and alignment.
• Integrated digital temperature controller with Pt100 sensor and PID algorithm, maintaining bath stability within ±0.3 °C over extended test durations (up to 6 hours).
• Programmable timer with audible end-of-test alert and non-volatile memory for up to 10 user-defined test protocols (including duration, cycle rate, and temperature setpoint).
• Robust frame constructed from corrosion-resistant anodized aluminum alloy and food-grade stainless steel components, suitable for cleanroom and GLP-compliant laboratory environments.
• Low-noise synchronous motor drive system delivering high positional repeatability and minimal mechanical drift across repeated operational cycles.
• Front-panel LED display showing real-time temperature, elapsed time, and remaining test duration; all parameters accessible without software dependency.

Sample Compatibility & Compliance

The RBY-4B accommodates standard USP/ChP-compliant disintegration baskets (22 mm diameter, 77.5 mm height) and supports simultaneous testing of six samples per run. It is validated for use with uncoated tablets, film-coated tablets, enteric-coated tablets (using pH-adjusted media), hard and soft gelatin capsules, and vaginal/rectal suppositories. Instrument performance aligns with regulatory expectations for equipment qualification: Installation Qualification (IQ) and Operational Qualification (OQ) documentation templates are provided. While the unit itself does not embed electronic audit trails, its mechanical design and analog-digital hybrid interface facilitate straightforward integration into GMP workflows requiring documented calibration (per ISO/IEC 17025), routine preventive maintenance logs, and traceable temperature verification using NIST-traceable thermometers.

Software & Data Management

The RBY-4B operates as a stand-alone benchtop instrument with no embedded firmware or proprietary software. All operational parameters are configured manually via front-panel controls; no PC connection, driver installation, or cloud synchronization is required. This architecture eliminates cybersecurity risks associated with networked lab devices and ensures uninterrupted functionality during power fluctuations or IT infrastructure outages. For laboratories implementing electronic recordkeeping, time-stamped test start/end events can be manually logged into LIMS or ELN systems. Optional external data loggers (e.g., HOBO UX100 series) may be deployed for continuous bath temperature monitoring, generating CSV files compatible with statistical process control (SPC) platforms such as Minitab or JMP.

Applications

• Routine QC release testing of finished pharmaceutical products against compendial disintegration limits (e.g., ≤30 min for uncoated tablets, ≤60 min for coated tablets per ChP).
• Formulation development support—comparing disintegration profiles across prototype batches with varying binder types, compression forces, or coating thicknesses.
• Stability study assessments under accelerated storage conditions (e.g., 40 °C/75% RH), evaluating physical integrity loss over time.
• Supplier qualification of excipients affecting wetting or capillary action (e.g., croscarmellose sodium, sodium starch glycolate).
• Educational use in pharmacy and pharmaceutics laboratories for teaching pharmacopeial methodology and QC fundamentals.

FAQ

Does the RBY-4B comply with USP <701> and ChP disintegration requirements?
Yes—the mechanical design, basket geometry, immersion depth, oscillation frequency, and temperature control range meet the dimensional and operational tolerances specified in USP General Chapter <701> and Chinese Pharmacopoeia Volume II Appendix XII A.
Is calibration certification included with shipment?
A factory-issued calibration report (covering temperature accuracy and cycle timing) is supplied. Users are responsible for periodic recalibration per internal SOPs or ISO/IEC 17025-accredited providers.
Can the unit operate with acidic or alkaline dissolution media?
Yes—provided the bath container is cleaned thoroughly after each use. The stainless-steel basket and support structure resist corrosion in pH 1.2 (simulated gastric fluid) and pH 6.8 (simulated intestinal fluid) media when rinsed promptly post-test.
What maintenance is required for long-term reliability?
Monthly inspection of basket mesh integrity, quarterly lubrication of guide rod bushings, and annual verification of motor torque consistency using a calibrated tachometer and load cell.
Is technical support available outside China?
Jiaxinhai provides remote troubleshooting via email and video call; spare parts (baskets, gaskets, temperature sensors) are stocked in EU and North American distribution hubs with lead times under 10 business days.